Veterinary Pharmaceutical Raw Material Manufacturing
Industri Bahan Baku Farmasi untuk Hewan
🏭 Section C — Manufacturing
Bali record: not blocked by the provincial restriction; national ownership and licensing rules still apply
Instrument locator: Perpres 10/2021 Pasal 3(1)(d) — no annex names this activity
Kelompok ini mencakup pembuatan dan pengolahan bahan obat, bahan pembantu untuk hewan, yang berasal dari bahan kimia, bahan alam, hewan dan tumbuh-tumbuhan termasuk yang berasal dari hasil biologis, seperti bahan obat-obatan, seperti antisera dan fraksi darah lainnya, vaksin dan preparat homeopatik, substansi aktif obat untuk bahan farmakologi dalam pembuatan obat-obatan, seperti antibiotik, vitamin, salisilik dan asam o-asetilsalsilik, pengolahan darah, gula murni kimia, garam farmasi, pengolahan kelenjar, dan ekstraksi kelenjar.
Source: the BPS 2020↔2025 conversion table, mechanically extracted and acceptance-gate verified. It shows which 2020 codes map to this 2025 code — provenance only, not a licensing claim: the regulatory regime of these predecessor codes has not been adjudicated as transferring.
These codes identify the PP 28/2025 regulatory rows used as licensing sources for this page. They are not the official BPS 2020 → 2025 crosswalk and do not establish predecessor ancestry.
Sources & Verification
Each data layer below traces to a government source with its KBLI vintage — or is declared as a gap. Nothing in these layers is silently filled in.
Title and scope as defined by the KBLI-2025 classification.
locator: OSS_RBA_2025_id_version_fff4053d
Risk category and licensing rows are KBLI-2025-native from the OSS Risk-Based Approach catalog.
locator: OSS_RBA_resiko_2025
The current whole-code foreign-ownership verdict has an adjudicated official basis and source vintage in the canonical record.
locator: Perpres 10/2021 Pasal 3(1)(d) + 3(2) (as amended by Perpres 49/2021): the residual category — «Bidang Usaha yang tidak termasuk dalam huruf a, huruf b, dan huruf c» — «dapat diusahakan oleh semua Penanam Modal». Derived from the instrument by ABSENCE, not from a row that names this code: over the BPS 2020→2025 crosswalk the code is on no Lampiran I (prioritas), Lampiran II (dialokasikan/kemitraan Koperasi-UMKM) or Lampiran III (persyaratan tertentu, foreign-ownership caps included) row — tested against Lampiran III BOTH by code through the crosswalk AND by activity title, because BPS re-scopes numbers between vintages while a cap attaches to the ACTIVITY the annex names — no body article names it (Pasal 2(2) closed list, Pasal 6(3a) alcohol trade) and no Pasal 11(2) sector-law referral reaches its SECTOR — the article's unit is «Bidang Usaha keuangan dan Bidang Usaha perbankan», so the whole of KBLI divisions 64, 65 and 66 is withheld from this lane, not merely the six codes the carve-out artifact enumerates. No instrument maps the 5-digit code; the residual article IS the locator. Open to all Penanam Modal, max foreign 100%. Scope: this is the Perpres investment axis only — sector statutes OUTSIDE the Perpres were not swept per code, and where that gap is load-bearing (divisions 09, 35, 49-53, 61: migas, ketenagalistrikan, pelayaran, penerbangan, pos, telekomunikasi) the codes are withheld from this lane rather than published under it. Four Pasal 2(2) items close an ACTIVITY and name no code (narkotika golongan I; perjudian/kasino; CITES species and koral; industri senjata kimia and bahan perusak lapisan ozon): they are tested here by the state's OWN per-code markers — the licensing requirement for a «Surat Pernyataan tidak memproduksi senjata kimia … Bahan Perusak Ozon/BPO», plus the hand-held exclusions for the alcohol, tobacco, explosives and CITES chains — and none of them reaches a code in this lot. This basis does not clear a closed ACTIVITY carried on under an open code. The OSS licensing gate (risk tier, scale, zoning, and for a PMA the Pasal 7(1) >Rp10bn Usaha Besar test) is a separate question this basis does not answer.
Conservative posture derived from the risk tier · confidence MEDIUM.
Dataset last updated 2026-09-25 · KBLI 2020 and KBLI 2025 reuse code numbers for different activities — cross-vintage rows are labeled, never merged silently.
Can foreigners operate a veterinary pharmaceutical raw material manufacturing business in Indonesia?
What license is required for KBLI 21014?
What is KBLI 21014?
How did KBLI 21014 change from KBLI 2020 to 2025?
Related Codes
Medical Diagnostics, Bandages & Health Support Devices
Industri Alat Diagnosis Medis, Perban, Kasa, dan Penunjang Kesehatan Lainnya
Veterinary Pharmaceutical Product Manufacturing
Industri Produk Farmasi untuk Hewan
Herbal Medicine Raw Material Manufacturing, Human
Industri Bahan Baku Obat Bahan Alam untuk Manusia
Human Pharmaceutical Product Manufacturing
Industri Produk Farmasi untuk Manusia
Herbal Medicine Product Manufacturing, Human
Industri Produk Obat Bahan Alam untuk Manusia
Human Pharmaceutical Raw Material Manufacturing
Industri Bahan Baku Farmasi untuk Manusia
Ready to register this business?
Bali Zero handles company setup, KBLI registration, NIB, and licensing for KBLI 21014.
PT PMA Setup
IDR 20.000.000
Company registration, KBLI, NIB, domicile
Virtual Office
IDR 5.000.000
Legal address for your company in Bali